Acumen Pharmaceuticals (NASDAQ:ABOS) Receives New Coverage from Analysts at Bank of America theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) saw a significant increase in short interest in June. As of June 30th, there was short interest totalling 191,400 shares, an increase of 26.8% from the June 15th total of 151,000 shares. Currently, 0.7% of the company’s stock are short sold. Based on an average daily trading […]
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 191,400 shares, a growth of 26.8% from the June 15th total of 151,000 shares. Based on an average daily trading volume, of 266,900 shares, the short-interest […]
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 151,000 shares, a decrease of 37.1% from the May 31st total of 240,200 shares. Based on an average daily volume of 190,100 shares, the […]
Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) and Fresh Tracks Therapeutics (NASDAQ:FRTX – Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership. Institutional & Insider Ownership 64.3% of Acumen Pharmaceuticals […]